GSK taps UK firm for "beyond antibodies" drug technology Reuters LONDON | Tue Jul 9, 2013 4:20am EDT. LONDON (Reuters) - GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody-based drugs ... |
